Duchenne muscular dystrophy Trials in Calgary, Canada
Conditions / Duchenne muscular dystrophy / Calgary, Canada
Duchenne muscular dystrophy has been the subject of sustained clinical investigation across multiple research sites.
31 total trials for this combination
Showing top 10 of 31 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01247207 | Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD) | COMPLETED | PHASE3 |
| NCT00592553 | Phase 2B Study of PTC124 (Ataluren) in Duchenne/Becker Muscular Dystrophy (DMD/BMD) | COMPLETED | PHASE2 |
| NCT02851797 | Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy | COMPLETED | PHASE3 |
| NCT04060199 | Study to Assess the Efficacy and Safety of Viltolarsen in Ambulant Boys With DMD (RACER53) | COMPLETED | PHASE3 |
| NCT02310763 | A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy | TERMINATED | PHASE2 |
| NCT02500381 | Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD) | COMPLETED | PHASE3 |
| NCT03373968 | Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study | RECRUITING | PHASE2/PHASE3 |
| NCT03439670 | A Study to Assess the Efficacy and Safety of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) | COMPLETED | PHASE2 |
| NCT04281485 | Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03532542 | An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy | TERMINATED | PHASE3 |